PROTECT MULTI AKTIENANLEIHE - SANOFI/RENAULT/DANONE Share Price

Certificat

DE000VM05B94

Delayed Deutsche Boerse AG 09:33:10 09/05/2024 BST
101 EUR -0.01% Intraday chart for PROTECT MULTI AKTIENANLEIHE - SANOFI/RENAULT/DANONE
Current month+0.11%
1 month-0.26%
Date Price Change Volume
09/05/24 101 -0.01% 0
08/05/24 101 -0.09% 0
07/05/24 101.1 -0.01% 0
06/05/24 101.1 +0.20% 0
03/05/24 100.9 +0.06% 0

Delayed Quote Deutsche Boerse AG

Last update May 09, 2024 at 09:33 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM05B9
ISINDE000VM05B94
Date issued 04/09/2023
Strike 98.03
Maturity 20/09/2024 (135 Days)
Parity 0.1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 103.3
Lowest since issue 94.05
Spread 5
Spread %0.49%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
93.08 EUR
Average target price
108.1 EUR
Spread / Average Target
+16.09%
Consensus